FDA report urges stronger warnings for acetaminophen

05/27/2009 | Bloomberg

An FDA working group released a report urging reduced doses of drugs containing acetaminophen and warnings about liver injury linked to such drugs. The report, which also advises against using acetaminophen in nonprescription combination products such as Tylenol Cold, will be discussed by FDA advisory panels June 29 and 30.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC